Nasopharyngeal Cancer: Background, Relevant Anatomy, Pathogenesis
Epstein‑Barr virus infection is associated with nasopharyngeal carcinoma.
Establishing the etiological role of EBV guides targeted screening, early detection, and the development of EBV‑based vaccines or antiviral therapies, potentially reducing incidence and improving outcomes for high‑risk populations.
Evidence level: Korai humán adat. Kis vagy feltáró emberi adat.
Related signals
- Anti‑PD‑1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double‑blind phase 3 study
- Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
- Nasopharyngeal Cancer
- Hierarchical dynamic model for risk‑stratified screening of nasopharyngeal carcinoma
- Expert consensus on the role of immunotherapy in nasopharyngeal carcinoma: clinical and economic perspectives from the GCC region